(Reuters) - The European Medicines Agency said on Wednesday there was no evidence so far linking AstraZeneca's COVID-19 vaccine to illnesses in two people who received it in Austria, one of whom died 10 days after being inoculated.
The Austrian national health authority suspended the use of a batch of the vaccine after a person who was vaccinated was diagnosed with multiple thrombosis and later died, and another was hospitalised with pulmonary embolism.
Already a subscriber? Log in
5.5 PAYDAY OFFER: 35% OFF Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
